Geron reported $804M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 195.44B 5.55B Jun/2026
Cassava Sciences USD 82M 14M Mar/2026
Cytokinetics USD 11.55B 3.36B Jun/2026
Exelixis USD 13.54B 2.65B Jun/2026
Genmab DKK 17.1B 88.06B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
Incyte USD 22.65B 3.92B Jun/2026
MacroGenics USD 184M 82M Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Novavax USD 1.09B 316M Dec/2025